Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

01-10-2018

https://doi.org/10.4081/dr.2018.7859

2114

PDF: 1090

HTML: 86
Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek

11-04-2025

https://doi.org/10.4081/dr.2025.10124

695

PDF: 449

HTML: 15
Hidradenitis suppurativa: state-of-the-art review and update

Marco Virone, Elena Zappia, Alberto Di Caro, Davide Carlesimo, Nicoletta Bernardini, Giovanni Pellacani, Antonio Giovanni Richetta, Steven Paul Nisticò, Annunziata Dattola

27-08-2025

https://doi.org/10.4081/dr.2025.10328

1308

PDF: 837

HTML: 17
Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

29-07-2021

https://doi.org/10.4081/dr.2021.8797

3157

PDF: 669

HTML: 19
Certolizumab to treat hidradenitis suppurativa

Asem Shadid, Saud Alobaida, Yousef Binamer

27-10-2022

https://doi.org/10.4081/dr.2022.9566

1982

PDF: 757

HTML: 53
Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

13-03-2025

https://doi.org/10.4081/dr.2025.10021

529

PDF: 353

HTML: 15
Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Eugenia Veronica Di Brizzi

21-02-2025

https://doi.org/10.4081/dr.2025.10278

504

PDF: 326

HTML: 24
Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

01-07-2025

https://doi.org/10.4081/dr.2025.10315

629

PDF: 323

HTML: 25
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

882

PDF: 469

HTML: 52
A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

Shinpei Miura, Kanako Tsunoda, Hiroo Amano

05-06-2023

https://doi.org/10.4081/dr.2023.9699

791

PDF: 477

HTML: 32
Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami

06-12-2024

https://doi.org/10.4081/dr.2024.10171

1848

PDF: 489

HTML: 56
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1120

PDF: 591

HTML: 96
Isotretinoin musculoskeletal side effects: a systematic review

Rahaf R. Almutairi, Atheer G. Almutairi, Afnan F. Alhallafi, Norah A. Almudawi, Mohammed Abdulaziz AlSulaiman, Asem M. Shadid, Ruaa Alharithy

12-04-2024

https://doi.org/10.4081/dr.2024.9845

6173

PDF: 1224

SUPPLEMENTARY: 465

HTML: 495
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1842

PDF: 740

HTML: 109
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1826

PDF: 564

HTML: 102
Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

Mitchell Hanson, McKenzie E. Maloney, Louis Kuchnir

08-02-2024

https://doi.org/10.4081/dr.2024.9866

1246

PDF: 777

HTML: 40
When anti-tumor necrosis factor-α backfires: paradoxical psoriasis and psoriatic arthritis in a patient with hidradenitis suppurativa

Chiara Del Re, Vincenzo Filastro, Gaia Fasano, Giancarlo Valenti, Domenico D'Amico

11-09-2026

https://doi.org/10.4081/dr.2026.10808

385

PDF: 156
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1224

PDF: 864

HTML: 49
Secondary prevention of hidradenitis suppurativa

Hjalmar Kurzen, Marina Kurzen

25-10-2019

https://doi.org/10.4081/dr.2019.8243

3115

PDF: 1252

HTML: 45
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2666

PDF: 657

HTML: 16
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

1125

PDF: 645

HTML: 51
Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani

04-02-2025

https://doi.org/10.4081/dr.2025.10232

566

PDF: 362

HTML: 26
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini

30-07-2025

https://doi.org/10.4081/dr.2025.10379

572

PDF: 390

HTML: 14
Treatment modalities of necrobiosis lipoidica: a concise systematic review

Amir Feily, Shadi Mehraban

08-06-2015

https://doi.org/10.4081/dr.2015.5749

3028

PDF: 1929

Suppl. Table: 457

HTML: 501
A microRNA focus on acne

Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

02-02-2024

https://doi.org/10.4081/dr.2024.9902

1157

PDF: 750

HTML: 73

1 - 25 of 35 items 1 2 > >>

Search

Search Results

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

Hidradenitis suppurativa: state-of-the-art review and update

Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Certolizumab to treat hidradenitis suppurativa

Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Adalimumab-induced facial erysipelas and its successful resolution with azithromycin in a 19-year-old female

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor α inhibitor

Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Isotretinoin musculoskeletal side effects: a systematic review

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Exploring the connection between hidradenitis suppurativa and erythema nodosum: a case report

When anti-tumor necrosis factor-α backfires: paradoxical psoriasis and psoriatic arthritis in a patient with hidradenitis suppurativa

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Secondary prevention of hidradenitis suppurativa

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

Treatment modalities of necrobiosis lipoidica: a concise systematic review

A microRNA focus on acne

authors

reviewers

Categories

indexing

dermatopathology